2022-03-31-accounts

		Page
Chair and CEO's Report
Trustees' Report
Independent Auditor's	Report	32
Statement of Financial	Activities	36
Balance Sheet		37
Statement of Cash Flows		38
Notes to the financial	statements	39

Potential Risk	Potential Risk	Potential		Impact				Steps to mitigate risk
Ongoing	impact	Potential		disruption	to	service		Flexible model ofservice delivery to ensure
ofthe pandemic		delivery		and	continued			best possible support is available for
		reduction		in traditional		income		patients despite restrictions.
		streams	due to Covid			related		Review fundraising activities to identify
		restrictions						opportunities for income generation/
								continued evolution of virtual events/
								exploration of grant funding opportunities.
								Income levels are closely monitored, and
								forecasts reflect prudent assumptions
								re ardin sustainable recove lans.
Cost of living		Reduction		of	disposable			As above plus implementation of
crisis		income leading to			reduction		in	fundraising plan to improve data analysis
		giving						/marketing to maintain and build on strong
								supporter relationships.
								Costs will be monitored and managed by
								the Finance and Income Generation
								Committee to be in line with any significant
								changes in income generation.

otential	isk,	isk,	'	Potential Im sct	Potential Im sct			St stoimfti	'te.risk
Succession				Insufficient staff	with		suitable	Comprehensive	review of staffing
planning	and			skills and experience to				requirements	is underway with phased
staffing levels				manage the	organisation/			recruitment	plans to ensure all
				deliver services				departments	are adequately resourced
								within financial	constraints
Cyber security				Possible financial,		regulatory		External IT	consultancy with regular
				and reputational			risks if	updates to cyber security systems. Staff
				system access	controls are			training to ensure awareness of risk and
				breached.				steps to take	in the event of a breach.
								Trustees are	considering further steps to
								ensure defence against cyber-attacks is
								appropriate and proportionate for the
								or anisation.
Relationship		with		This is a crucial		partnership,		Trustees and	management continue to re-
the Royal	Devon			and it is essential		that robust		establish and	maintain relationships with
fails to be				arrangements are		in	place to	key Royal Devon staff and executives.
formalised				formalise the		contractual		Clarifications re staffing arrangements was
effectively				relationship including			service	sought from	HMRC in July 2021 but a
				delivery /			staffing	response has	yet to be received. Formal
				arrangements	in		light of	negotiations with the Royal Devon will
				HMRC clarification			re VAT	proceed once HMRC clarification is
				treatment				received.

Registered	Registered	Address:	Address:			FORCE Cancer Charity
						Corner House
						Barrack Road
						Exeter
						EX25DW Tek 01392402875
Registered		Charity	Number:			1140676
Registered		Company		Number:		07529991
Patron:						Dr Nigel Acheson
Vice-Patrons:						Mr David Cantle
						Mr Mervyn Hayes
Trustees:						Dr Anne Hong —Chair
						Mr Morley Sage —Vice Chair
						Mrs Ruth Boobier
						Mr Frank Cook
						Dr Jenny Forrest
						Dr Sally Kidner
						Mrs Louise Mayor
						Mr Felix Medland
						Mr John Renninson
						Mr Jeremy Roberts
						Mrs Sally Tapp
						Dr Christina Thirlwell
Chief Executive Officer:						Mrs Meriel Fishwick
Finance	&	Income	Generation		Committee:	Mr Morley Sage - Chair
						Dr Anne Hong
						Mr Felix Medland
						Mrs Meriel Fishwick —Chief Executive Officer
						Mrs Julia Pitts —Chief Finance Officer
						Mrs Sarah Daniels —Head	of Income	Generation	(resigned	8
						February 2022)

Governance	Committee:		Mr John Renninson —Chair (resigned	Mr John Renninson —Chair (resigned	Mr John Renninson —Chair (resigned	from	from	GC 4 February 2022)	GC 4 February 2022)	GC 4 February 2022)	GC 4 February 2022)	GC 4 February 2022)	GC 4 February 2022)
			Mr Jeremy Roberts —Chair		(appointed			Chair		of	GC from		4
			February 2022)
			Dr Jenny Forrest
			Dr Anne Hong
			Mr Morley Sage
			Mrs Meriel Fishwick —Chief Executive			Officer
			Mrs Julia Pitts —Chief Finance		Officer
			Mrs Sarah Daniels —Head	of Income			Generation				(resigned		8
			February 2022)
Operational	Management	Team:	Mrs Meriel Fishwick —Chief Executive			Officer
			Mrs Julia Pitts —Chief Finance		Officer
			Mrs Sarah Daniels —Head	of Income			Generation				(resigned		8
			February 2022)
			Mrs Emma Ellis —Psycho-Oncology Services						Manager			(resigned
			from OMT 31 March 2022)
			Mrs Gait Allen —Finance Team		Manager		(appointed				15	February
			2022)
			Miss Naomi Cole —Community		Fundraiser			(appointed			15
			February 2022)
			Mrs Heather Taybr —Volunteer		Co-ordinator				(appointed			15
			February 2022)
			Mr Oliver Watts —Fundraising		Development			Officer		(appointed			15
			February 2022)

			Unrestricted	Designated	Restricted	Total	Total
		Note	funds	funds	funds	2022	2021
			E	2	f	2	2
Income:
Donations and legacies			366,824		85,702	452,526	829,016
Other trading activities			555,120			555,120	386,050
Charitable activities			7,824			7,824	2,593
Investment income			13,862			13,862	21,443
Other income			3,306			3,306	3,251
Total income			946,936		85,702	1,032,638	1,242,353
Expenditure:
Expenditure on raising funds			382,359	11.386	1,100	394.845	378,401
Expenditure on charitable	activities		740,210	50,234	119,838	910,282	998,957
Total resources expended			1,122,569	61,620	120,938	1,305,127	1,377,358
Net gains/(losses) on investments		17	19,681			19,681	91,110
Net income/(expenditure)			(155,952)	(61,620)	(35,236)	(252,808)	(43,895)
Transfers between funds		22/23	(19,273)	19,273
Net movement in funds			(175,225)	(42,347)	(35,236)	(252,808)	(43,895)
Funds at 31 March 2021			1,182,811	269,687	156,329	1,608,827	1,652,722
Funds at 31 March 2022			1,007,586	227,340	121,093	1,356,019	1,608,827

Balance S	heet		Company	registered	number 07529991
					2022	2021
			Note		8	2
Fixed assets
Tangible assets			16		179,999	264,632
Investments			17			305,979
					179,999	570,611
Current assets
Stocks					6,016	7,084
Debtors			18		138,501	93,995
Investments					170,000	170,000
Cash at bank	and	in hand			1,139,222	1,093,075
Total current	assets				1,453,739	1,364,154
Liabilities
Creditors falling due within one year					(277,719)	(325,938)
Net current assets					1,176,020	1,038,216
Net Assets					1,356,019	1,608,827
The funds of	the	charity
Unrestricted	funds
General funds	- free reserves				889,799	1,037,180
General funds	- fixed asset reserve				117,783	145,631
					1,007,582	1,182,811
Designated funds			22		227,341	269,687
					1,234,923	1,452,498
Restricted funds			23		121,096	156,329
Total charity	funds		21		1,356,019	1,608,827

Year Ended 31 March 2022	Year Ended 31 March 2022	Year Ended 31 March 2022
Statement ofCash Flows
						Note	2022	2021
Cash provided by/(used in)		operating	activities			27	(292,414)	63,499
Cash flows from investing		activities
Dividends,	interest and rents	from investment					13,862	21,443
Purchase	of property plant and equipment						(961)	(8,472)
Proceeds	from sale of investments						399,171	300,163
Purchase	of investments						(82,722)	(83,927)
Cash used in investing activities							329,350	229,207
Changes	in cash and cash	equivalents	in the	reporting	period		36,936	292,706
Cash and	cash equivalents	at the beginning		ofthe			1,272,286	979,580
reporting	period
Cash and	cash equivalents	at the end	ofthe	reporting		28	1,309,222	1,272,286
period

	Notes to the financial statements
3.	Donations and Legacies
		2022	2021
		2
	Legacies	207,151	264,151
	In memoriam	38,138	40,984
	Donations	89,923	209,470
	Gift Aid	46,062	77,196
	Grants	71,252	237,215
		452,526	829,016

rading Ac	tivities
		2022	2021
Collecting	boxes	10,692	7,117
Fundraising	Events	350,286	243,562
Sales of goods and services		5,934	6,368
Shop sales		188,208	129,003
		555,120	366,050

le activities
	2022	2021
Oncology coffee bar	2,071	213
Sale of support services stock	3,892	219
Other charitable activities	1,861	2,161
	7,824	2,593

6.	Investment Income
					2022	2021
						2
	Interest received				830	3,091
	Flat rent				6,975	6,675
	Dividend income				6,057	11,677
					13,862	21,443
	All income is unrestricted.
7.	Other Income
					2022	2021
					2
	Sundry				3,306	3,251
					3,306	3,251
	All income is unrestricted.
8.	Expenditure on generating		funds
					2022	2021
						5
	Shop expenditure				165,685	161,644
	Fundraising	events			220,520	206,006
	Goods for resale				4,428	4,233
	Investment	management		costs	4,212	6,316
					394,845	376,401

Notes to the financial statements	Notes to the financial statements
Expenditure on charitable activities
		Note	2022	2021
			8	2
Patient support costs			670,714	607,928
Outreach costs			36,178	197,199
Innovation grants payable		10	1,882	9,100
Research and expenditure	grants	11	24,250	3,958
Support services stock sold			5,191	2,241
Extension depreciation			36,767	36,767
Database depreciation			3,474	10,027
Oncology coffee bar			10,253	9,402
Administrative support costs		12	99,436	103,438
Governance costs		13	22,137	18,897
			910,282	998,957

			Unrestricted	Designated	Restricted	Total	Total
			Funds	funds	funds	2022	2021
			2	2	2	2	2
Donated	equipment						7,600
Education				1,882		1,882	1,500
Other innovative		projects
				1,882		1,882	9,100

11.Research	expenditure	and	grants
				Total	Total
				2022	2021
				2	2
Research	grant			24,250	3,958
				24,250	3,958

			Total	Total
			2022	2021
			2	8
Seconded staff costs			84,186	87,625
Travel and motor				26
Pffnting,	postage and stationery		1,261	1,124
Computer	and website costs		5,604	5,876
Insurance			121	113
Bank charges		and interest	1,230	1,407
Training	and conferences		324	228
Depreciation			2,378	2,596
Irrecoverable		VAT	1,282	1,450
Sundry			3,050	2,993
			99,436	103,438

nce cos	ts
			2022	2021
			2	8
Audit and	accountancy		11,470	10,670
Trustees'	indemnity	insurance	688	570
Seconded	staff costs		9,903	7,619
Legal costs
Sundries			76	38
			22,137	18,897

to the	financial statemen	ts
sts			2022	2021
			8	8
Salaries	and wages		720,686	748,232
Social security costs			63,288	63,610
Pension	contributions		92,804	98,937
			876,778	910,979
			No.	No.
Average	number of staff		29	32
Average	number of FTE staff		20	22
ere two	members staff working	at FORCE in receipt of emoluments	(gross salary	plus employe
contributions) exceeding 260,000 (2021:two).
			2022	2021
			No.	No.
260,000	- 269,999		1	2
270,000	- 279,999		1

	Freehold	Leasehold	Leasehold	Motor	Office 8 shop	Total
	land &	property	improvements	Vehicles	equipment
	buildings	(shop)	(centre)
	2	2	2
Cost
At 1 April 2021	127,238	111,892	435,388	51,116	207,066	932,700
Additions					961	961
Dispossls					(4,124)	(4,124)
At 31 March 2022	127,238	111,892	435,388	51,116	203,903	929,537
Depreciation
At 1 April 2021	49,307	68,180	368,207	32,540	149,834	668,068
Charge for year	3,005	11,018	42,587	6,798	22,186	85,594
Dispossls					(4,124)	(4,124)
At 31 March 2022	52,312	79,198	410,794	39,338	167,896	749,538
Net book values
At 31 March 2022	74,926	32,694	24,594	11,778	36,007	179,999
At 31 March 2021	77,931	43,712	67,181	18,576	57,232	264,632

		2022	2021
Market value at 1 April		305,979	458,039
Additions		82,722	83,927
Disposals		(399,171)	(300,163)
Gain/(loss)	on investments	19,681	91,110
Movement	in cash holdings	(9,211)	(26,934)
Market value at 31 March			305,979
Historical	cost at 31 March		248,577
Listed investments:		2022	2021
UK Bonds			70,647
UK Equities			50,877
Overseas	Equities		123,322
Other			51,922
Cash			9,211
Market value at 31 March			305,979

	2022	2021
	8
Other debtors	123,806	74,532
VAT refund	3,419	2,167
P repayments	11,276	17,296
	138,501	93,995
	2022	2021
	2
Trade creditors	173,355	237,560
Other creditors	76,762	49,842
Accru ale	27,602	38,536
	277,719	325,938

At 31 March 2022 the Charity had annual below:	commitments under	non-cancellable	operating leases as set out	operating leases as set out
		2022	2021
	Plant and	Land &	Plant &	Land &
	machinery	buildings	machinery	buildings
	5	2	2	2
Operating leases which expire:
In less than 1 year	12,481	21,806	15,082	23,775
Within 2 to 5years	16,958	51,100	25,307	86,663
In more than 5years		131	~	156
	29,439	73,037	40,389	110,594

	At the year-end there was a capital commitment	of anil (2021:anil).
21.	Movement on Funds
		Unrestricted	Designatednestricted
		funds	funds	funds	Total
		8	2	8
	At 1 April 2021	1,182,811	269,687	156,329	1,608,827
	Surplus I (deficit) for the year after transfers	(175,225)	(42,347)	(35,236)	(252,808)
	At 31 March 2022	1,007,586	227,340	121,093	1,356,019

22.	Designated funds
			At	Incoming	Expenditure	Transfers	Balance
			1.4.21				31.3.22
			2				2
	patient Support
	FORCE@locations		2,359		(20,628)	19,273	1,014
	Innovation		166,378		(26,132)		140,246
	Centre Fixed Assets		3,474		(3,474)
	Shop Renovations	I Dilapidations	97,465		(11,386)		86,080
			269,687		(61,620)	19,273	227,340
	2021 Designated	funds	At	Incoming	Expenditure	Transfers	Balance
	Comparative		1.4.20				31.3.21
			2				6
	Patient Support
	FORCEetlocations		3,724		(137,826)	136,471	2,369
	Innovation		167,878		(1,500)		166,378
	Centre Fixed Assets		13,501		(10,027)		3,474
	Shop Renovations	IDilapidations	108,852		(11,386)		97,466
			293,955		(160,739)	136,471	269,687

2022	net assets between	funds
			Unrestricted	Designated	Restricted
			funds	funds	funds	Total
			2	2	2	6
	Tangible fixed assets		117,783	57,095	5,121	179,999
	Fixed asset investments
	Cash at bank and	in hand	1,023,005	170,245	115,972	1,309,222
	Other net current	assets	(133,202)			(133,202)
			1,007,586	227,340	121,093	1,356,019
2021	net assets between	funds
	Comparative
			Unrestricted	Designated	Restricted
			funds	funds	funds	Total
				8	2	2
	Tangible fixed assets		145,631	73,309	45,692	264,632
	Fixed asset investments		305,979			305,979
	Cash at bank and	in hand	956,060	196,378	110,637	1,263,075
	Other net current	assets	(224,859)			(224,859)
			1,182,811	269,687	156,329	1,608,827

Financial	instru	ments
										2022	2021
										8	2
Financial	assets	measured	at	fair	value	through	tncome	and	expenditure		305,979

					2022	2021
					2	f
	Net income/(expenditure)		for the reporting	period	(252,808)	(43,895)
	Adjustments for:
	Depreciation charge				85,594	94,290
	(Gains)/losses on investments				(19,681)	(91,110)
	Dividends, interest and rents from investment				(13,862)	(21,443)
	Decrease/ (Increase)	in stock			1,068	(1,201)
	(Increase) in debtors				(44,506)	(49,038)
	(Decrease)/ Increase	in creditors			(48,219)	175,896
	Net cash provided by/ (used in) operating			activities	(292,414)	63,499
28.	Analysis ofcash and	cash	equivalents
					2022	2021
					f
	Cashin hand				1,139,222	1,093,075
	Fixed asset investments					9,211
	Current asset investments				170,000	170,000
	Total Cash and Cash	equivalents			1,309,222	1,272,286